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An important aspect of the economic gap between developed and
developing countries is the huge disparity in the health conditions experienced
in the rich and poor parts of the world. The physical and economic burdens
of diseases affect peoples in the developing world more significantly than they
do those in developed countries. In its 1999 World Health Report, the World
Health Organization (WHO) stated that "[d]espite the long list of success in
health achieved globally during the 20th century, the balance sheet is indelibly
stained by the avoidable burden of disease and malnutrition that the world's
disadvantaged populations continue to bear."' While WHO and other
international organizations have tried to reduce the "health gap" between
developed and developing countries,2 experts point to much evidence that the
health gap still remains of daunting and, in some cases, worsening
proportions. WHO argues that populations in developing countries now face
not only continued threats from infectious diseases but also growing
epidemics of non-communicable diseases, such as lung and heart disease.'
The continued presence of the global health gap becomes more worrisome
when arguments that the processes of globalization are increasing, rather than
narrowing, the gap are considered.
The claim that the globalization of markets, laws, and culture adversely
affect the health of peoples in developing countries deserves specific attention
when analyzing perspectives on globalization from developing States because
the health area provides excellent material for evaluating the differential
* Associate Professor of Law, Indiana University School of Law-Bloomington, M. Phil., University
of Oxford (1988); J.D., Harvard Law School (1991); B.C.L., University of Oxford (1991). I would like to
thank Lezlie Willis for her skilled research assistance.
I. WORLD HEALTH ORGANIZATION, THE WORLD HEALTH REPORT 1999: MAKING A DIFFERENCE
13 (1999) [hereinafter WORLD HEALTH REPORT 1999].
2. Id. ("Reducing the burden of that [health] inequality is a priority in international health.").
3. Id. at 13-17, 19-20.
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impact of globalization in international relations. Analyzing the health-
globalization relationship proves, however, to be a very complex business
because both "health" and "globalization" are complicated concepts. Health,
for example, is a composite value: to achieve a condition of individual health
requires multiple inputs from multiple sources at the personal, familial, local,
national, and international levels." Thus, the points at which the processes of
globalization can affect the health of a person or society are many. Likewise,
the processes of globalization are many and complex, ranging from formal
international legal structures, such as the World Trade Organization (WTO),
to the subtle influences of the globalization of certain cultural images and
practices on individuals' decisions about diet, sexual behavior, and health
care.
This Article explores the health-globalization relationship to contribute
modestly to thinking about globalization from the perspective of the
developing world. Much of my attention will be focused on the impact of the
globalization of markets on public health and health care in developing
countries because it is in this area that much sound and fury has already
developed about globalization and its champions. Part I briefly outlines the
health gap between developed and developing countries to provide some
empirical context for the analysis that follows. This outline includes not only
data on the relative burdens of infectious and non-communicable diseases in
developed and developing countries, but also looks at the "health transition"
strategy that was designed to close the health gap between rich and poor
countries.
Part II examines some of the claims being made about the adverse effects
that globalization is having on public health and health care in developing
countries. Central to these claims is a health-oriented critique of liberal or
neo-liberal economic thinking perceived to be animating the institutions and
rules regulating the world economic system. In caricature, the critique asserts
that health in developing countries is being sacrificed on the alter of neo-
liberalism in a ritual that benefits the rich. Interestingly, the critique focuses
more on the policies of the World Bank and International Monetary Fund
(IMF) than on those of the WTO. In this focus can be found a divergence
between developed States' concerns with public health threats spreading to
their shores through international trade, and developing countries' concerns
4. See id. at 6 (noting the multisectoral determinants of health).
NEITHER SCIENCE NOR SHAMANS
with the impact of "structural adjustment programs" and general global
economic competition on national public health and health care.
Part III moves into the theoretical realm by asking whether liberal or neo-
liberal economic thinking, applied globally and locally, adequately values
health as an objective. This line of analysis brings to the forefront
controversies about the so-called "human right to health," one of the
economic, social, and cultural human rights. In this context, we face the
uncomfortable accusation that liberal thinking and its manifestations in
globalization processes foment violations of a basic human right. My analysis
suggests, however, that much of the problem rests not with neo-liberal
economic thinking, but with the concept of the "right to health," a concept that
packs more rhetorical punch than policy or legal guidance for States or
international organizations.
Part IV focuses on a different aspect of the health-globalization
relationship that is central to future thought and action: the future of
traditional medicine in developing countries. Any project to improve health
conditions in many developing countries, particularly those in Africa, has to
confront how to meld modern, Western approaches to diseases with the
approaches of traditional cultures. Such melding could take different forms.
It could be a medico-paternalistic (or medico-imperialistic, depending on your
viewpoint) effort designed to educate the ignorant about the scientific
understandings of ill-health. It could be a cultural relativistic approach that
denigrates "Western" medical-health strategies in the context of traditional
cultures. No matter the approach, I argue that this melding process will be
affected, for better and for worse, by the globalization of Western economic
and cultural norms that ultimately affect health decisions of individuals and
governments. In other words, "traditional medicine" will cease to be a useful
concept in the global era, not because Western medicines and medical
technologies become universally available in developing countries, but
because the traditional cultures themselves are eroding and will continue to
erode under the onslaught of the globalization of Western economic culture.
I conclude by arguing that on the horizon is a future in which people in
developing countries may find themselves in the worst of all possible worlds
from a health perspective: they will not have access to Western medical care
and standards of public health, and they will have lost their faith in traditional
medicine and its cultural underpinnings. This situation represents a double
cultural alienation and a crisis for global public health and any concept of the
right to health.
1999]
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I. THE HEALTH GAP BETWEEN DEVELOPED AND DEVELOPING COUNTRIES
Despite the proclamation in 1946 of the .fundamental human right to
health in the WHO Constitution5 and the efforts of the WHO to achieve
"health for all,"6 health conditions greatly differ between developed and
developing countries. Historically, infectious diseases wrought the most
serious morbidity and mortality damage in most societies. Industrialized
countries in Europe and North America began breaking the grip of infectious
diseases in the late nineteenth and early twentieth centuries primarily through
basic improvements in sanitation, personal hygiene, and public health.' The
discoveries of effective vaccines and antibiotics in the second half of the
twentieth century further advanced health in the developed world.' Public
health experts and scientists argued that developed countries had passed
through a seminal health transition: from the stage where infectious diseases
were the leading cause of premature death, to the stage where chronic
diseases, such as various heart diseases, lung disease, and cancer, imposed the
greatest health burdens.9
As became clear in the post-World War II period of decolonization,
developing regions of the world were far from passing through the health
transition already experienced by developed societies. While vaccines,
antibiotics, and other Western medical breakthroughs were increasingly
available to governments and people in developing countries through national
and international programs," massive problems remained in terms of basic
sanitation and public health that would take decades more to overcome. The
goal of developed States, international health organizations, and health-related
non-governmental organizations (NGOs) was to move developing countries
5. WORLD HEALTH ORGANIZATION CONST. preamble, opened for signature July 22, 1946,62 Stat.
2679, 14 U.N.T.S. 185.
6. See International Conference on Primary Health Care, Declaration ofAlma-Ata, Sept. 12, 1978
(visited Sep. 5, 1999) <http://wwwl.umn.edu/humanrts/disabled/alma-ata.htm> [hereinafter Declaration
of Alma-Ata].
7. See David P. Fidler, The Globalization of Public Health: Emerging Infectious Diseases and
International Relations, 5 IND. J. GLOBAL LEGAL STUD. II. 26 (1997) (noting that "[i]mprovements in
public sanitation and hygiene within European and North American cities during the late-nineteenth and
early-twentieth centuries have had significant impact on the spread of infectious diseases").
8. Id. at 27.
9. WORLD HEALTH REPORT 1999, supra note 1, at 13 (observing that there has been a "20th century
revolution in health" and that "[tihis epidemiological transition results in a major shift in causes of death
and disability from infectious diseases to noncommunicable diseases").
10. Fidler, supra note 7, at 28.
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through the health transition to the point where infectious diseases were under
control and non-communicable diseases posed the biggest health challenge.
The shift in emphasis from infectious to non-communicable diseases would
be a sign of economic, public health, medical, and social development in
developing countries.
Recent analysis of the state of public health in the world demonstrates that
most developing countries have not passed through the health transition. As
WHO observed in its 1999 World Health Report, "[t]he populations of
developing countries and particularly the disadvantaged groups within those
countries remain in the early stages of the epidemiological transition.""
While health conditions have improved in many developing countries, as life
expectancies have generally increased and infant mortality rates generally
decreased, infectious diseases remain the leading cause of premature death.'2
In some respects, the infectious disease problem in developing countries is
getting worse, as evidenced by the spreading and deepening of the HIV/AIDS
crisis, 3 the continued death and illness caused by water-borne diseases such
as cholera, 4 and the development of antimicrobial resistance in killers such
as malaria, pneumonia, and tuberculosis. 5
Developing countries face, however, a growing crisis with non-
communicable diseases at the same time they face the continued, and in some
areas increasing, threat of infectious diseases. WHO sees on the horizon a
global pandemic of non-communicable diseases related to tobacco
consumption that has the potential to surpass even the burden of infectious
diseases in developing countries. 6 In addition, WHO has warned of the
development of a global obesity crisis which will further adversely affect
health in developing countries through obesity-related non-communicable
I1. WORLD HEALTH REPORT 1999, supra note I, at 20.
12. Id. (noting that "infectious diseases are still the major cause of death" in developing countries).
13. For statistics on the global HIV/AIDS crisis, see UNAIDS, AIDS Epidemic Update: December
1998, at 2 (1998) (visited Nov. II, 1999) <http://www.who.int/emc-hiv/decemberl998/wadr98e.pdf>.
UNAIDS estimates that "Imlore than 95% of all HIV-infected people now live in the developing world"
and that "[tihe epidemic has not been overcome anywhere... and the epidemic is frankly out of control
in many places." Id.
14. See, e.g., Cholera in 1997: Summary, 73 WKLY. EPIDEMIOLOGICAL REC., July 3, 1998, at 201
(noting "dramatic ch6lera epidemic affecting the countries in the Horn of Africa").
15. WORLD HEALTH REPORT 1999, supra note 1, at 22 (stating that "antimicrobial resistance is a
worrying phenomenon since it could have great adverse effects on the control and treatment of diseases
such as pneumonia, tuberculosis, and malaria").
16. See id. at 67 (stating that "on current smoking patterns, by the third decade of the next century,
smoking is expected to kill 10 million people annually worldwide-more than the total of deaths from
malaria, maternal and other major childhood conditions, and tuberculosis combined. Over 70% of these
deaths will be in the developing world").
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diseases. 7 Developing countries thus confront what WHO calls a "double
burden"' 8 for public health in the new millennium: continuing or increasing
burdens from infectious diseases and increasing sickness and death from non-
communicable diseases.
Not only has the "health gap" between developed and developing
countries not disappeared, but it has also changed its nature. Previously, the
gap was basically measured in terms of the burden of infectious diseases;
countries were supposed to make the transition away from infectious diseases
toward non-communicable diseases. Today and in the future, the gap is and
will be measured in terms of the burdens of both infectious and non-
communicable diseases. Any future "health transition" strategy now must aim
to reduce the burdens of both infectious and non-communicable diseases-a
public health undertaking of enormous proportions. The scale of the challenge
can be glimpsed by briefly noting that it requires governments in developing
countries (with international assistance)to improve basic sanitation and public
health systems, make better use of antimicrobial treatments to prevent the
development of resistant pathogens, and alter individual behavior patterns that
produce morbidity and mortality, such as tobacco consumption, promiscuous
sexual behavior, illicit drug use, and poor dietary habits. Where the economic
resources to undertake such massive and expensive public health endeavors
will originate remains a mystery. 9 The mystery becomes even more
forbidding when we begin to factor in the public health and health care
implications of the globalization of markets and culture.
II. GLOBALIZATION AND HEALTH IN DEVELOPING COUNTRIES
Public health and health care in developed and developing countries have
not escaped the impact of the processes of globalization. In fact, experts have
identified the phenomenon of the "globalization of public health," under
which States are losing the ability to protect the health of their publics from
17. World Health Organization, Obesity Epidemic Puts Millions at Riskfrom Related Diseases, Press
Release WHO/46,June 12, 1997 (visited Sep. 12, 1999) <http://www.who.int/archives/inf-pr-1997/en/pr97-
46.html>. See also World Health Organization, Obesity: Take It Seriously, Deal with It Now, WHO
Feature No. 190, Mar. 1996 (visited Sep. 12, 1999) <http:www.who.int/ncd/feat 190e.htm>.
18. WORLD HEALTH REPORT 1999, supra note I, at 14.
19. WHO argues that "financial resources for health lie overwhelmingly within countries .... Only
a tiny fraction of resources for health in low and middle income countries originates in the international
system-development banks, bilateral development assistance agencies, international nongovernmental
organizations, foundations and WHO." Id. at 83.
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disease threats.2" The loss of the ability to provide for public health because
of global forces is, of course, a matter of concern for developed as well as
developing countries. But, as in other areas of globalization, the impact on
developing countries is of a different magnitude in the health context because
the health threats are greater and the financial, technological, and human
resources to deal with them are smaller.
The relationship between globalization and health is complex; but it is
necessary, even at the risk of oversimplification, to clarify how the processes
of globalization adversely affect health in developing countries. From the
broadest perspective, the adverse health effects from globalization in
developing countries arise from structural imbalances in the international
system that the processes of globalization exacerbate. The structural
imbalances can be glimpsed through four features of globalization: (1)
increases in international trade; (2) structural adjustment programs maintained
by international financial organizations; (3) increases in international trade in
services and in transnational investments in service industries; and (4) the
international regime on intellectual property.
A. Increases in International Trade
In literature on the globalization of public health, the contributions of
international trade in goods to the global spread of diseases are often
highlighted.2 1 Increases in international trade in food provide opportunities
for food-borne pathogens, toxins, and potential carcinogens to spread to new
populations. 22  The increased scale of tobacco exporting by the major
transnational tobacco conglomerates fuels the consumption of tobacco in
20. See, e.g., Fidler, supra note 7; Gill Walt, Globalisation of International Health, 351 LANCET 434
(1998); Derek Yach & Douglas Bettcher, The Globalization of Public Health, I: Threats and
Opportunities, 88 AM. J. PUB. HEALTH 735 (1998); Derek Yach & Douglas Bettcher, The Globalization
of Public Health, I: The Convergence of Self-Interest and Altruism, 88 AM. J. PUB. HEALTH 738 (1998);
Vincent Navarro, Comment: Whose Globalization?, 88 AM. J. PUB. HEALTH 742 (1998).
21. See Fidler, supra note 7, at 31; Yach & Bettcher, The Globalization of Public Health, I, supra
note 20, at 737; David P. Fidler, Trade and Health: The Global Spread of Diseases and International
Trade, 40 GERM. Y.B. INT'L L. 300 (1997).
22. See, e.g., F. K. Kiferstein et al., Foodborne Disease Control: A Transnational Challenge,
3 EMERGING INFECTIoUs DISEASES, October-December 1997, at 503. In the late 1990s, a number of high-
profile situations have arisen in which States have acted to block the spread of infectious diseases or
carcinogens through international trade, including the trade restrictions adopted by countries in response
to bovine spongiform encephalopathy in the European Union, the "chicken flu" outbreak in Hong Kong,
the Nipah virus outbreak in Malaysia, and dioxin contamination of poultry from Belgium.
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developing countries, leading to more non-communicable disease problems.23
Some experts claim that neo-liberal free trade agreements, such as the General
Agreement on Tariffs and Trade (GATT), WTO, and North American Free
Trade Agreement (NAFTA), contribute significantly to the public health
threats related to increases in international trade." The globalization of the
markets for food products places stress on public health in developed and
developing States.
The health threats from increased international trade are not, however,
identical for developed and developing States. Much of the worry about
international trade spreading food-borne pathogens has been generated in
developed countries because they fear the importation of infections from
developing regions of the world." This worry reflects the infectious disease
gap between developed and developing countries. The globalization processes
of trade have become transnational pathogen superhighways. The concern,
from the perspective of developing countries, is whether the policing of this
microbial traffic by developed States and international trade organizations
deals fairly with developing countries.
Under existing international trade law, States have the sovereign right to
restrict trade to protect human, animal, and plant life and health.26 This right
is, however, subject to scientific and trade-related disciplines. Trade-
restricting health measures must be based on a risk assessment and be
supported by scientific evidence. In addition, scientifically justified trade-
restricting health measures have to be "necessary," in the sense that they are
the least trade-restrictive measures possible." Given the scientifically
23. See WORLD HEALTH REPORT 1999, supra note I, at 71 ("In the past few decades, transnational
tobacco conglomerates have made tremendous inroads into the markets of poor and middle income nations
in Africa, Asia, Eastern Europe and Latin America."). On globalization and the tobacco problem, see Derek
Yach & Douglas Bettcher, Globalization of Tobacco Marketing, Research, and Industry Influence:
Perspectives, Trends and Impacts on Human Welfare (visited Aug. 23, 1999)
<http://www.who.intltohfTFl/globalization.htm>. For analysis on the link between trade and tobacco, see
Allyn L. Taylor, An International Regulatory Strategy for Global Tobacco Control, 21 YALE J. INT'L L.
257 (1996); Fidler, supra note 21, at 305-08, 316-17, 351-53.
24. See, e.g., CHRIS McGINN ET AL., PUBLIC CITIZEN GLOBAL TRADE WATCH, NAFTA'S BROKEN
PROMISES: FAST TRACK TO UNSAFE FOOD (1997).
25. David P. Fidler, Mission Impossible? International Law and Infectious Diseases, 10 TEMPLE
INT'L& COMP. L.J. 493, 500 (1996) (arguing that "the attention being generated on E[merging] lInfectious]
D[isease]s comes mainly from the developed world, which fears the spread of infectious diseases from the
developing world").
26. DAVID P. FIDLER, INTERNATIONAL LAW AND INFECTIOUS DISEASES 122-23 (1999).
27. Id. at 138-46 (analyzing the science-based disciplines of the WTO Agreement on the Application
of Sanitary and Phytosanitary Measures [hereinafter SPS Agreement]).
28. Id. at 150-51 (analyzing the "necessary" requirement in the SPS Agreement).
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legitimate public health worries about pathogenic microbes spreading from
developing to developed regimes through international trade, this body of
international trade law seems tailor-made for developed countries to restrict
trade from developing countries. For example, in November 1998,
Zimbabwe's Deputy Minister of Health and Child Welfare "reported that
African meat exports to the EU are being rejected due to weak food control
systems in African countries."29
Under the WTO, this regime for sanitary and phytosanitary (SPS)
measures has mainly, however, been the subject of dispute between developed
countries, as illustrated by the Beef Hormones Case (United States and
Canada v. European Union), Australian Salmon Import Case (Canada v.
Australia), and Japanese Agricultural Products Case (United States v.
Japan)." The WTO's SPS regime has not, to date, been used extensively by
developed countries against developing countries. This evidence of inactivity
is not to imply that all is well with the SPS regime under the WTO from the
perspective of developing countries. While developed countries seem willing
to litigate SPS disputes, developing countries have not challenged trade-
restricting health measures of developed countries that violate international
trade law. A good example of such measures can be found in the European
Union's (EU) ban on the importation of fresh fish from East African countries
after these countries suffered cholera epidemics in late 1997 and early 1998."'
WHO and the U.N. Food and Agriculture Organization (FAO) both made it
clear that trade restrictions, such as those imposed by the EU, were not
appropriate in dealing with cholera. 2 Despite the lack of a legitimate
scientific and public health justification for its import ban, the EU kept it in
place for six months, causing millions of dollars in damage to fishery
29. Meaty Trade Issues, 2 BRIDGES WKLY. TRADE NEWS DIG., Nov. 16, 1998 (visited Sept. 27,
1999) <http://www.newsbulletin.org/bulletins/getbulletin.CFM?SID=>.
30. See WTO Appellate Body Reports on (I) EC-Measures Concerning Meat and Meat Products
(Hormones), WTO Doc. WT/DS26/AB/R & WT/DS48/AB/R (Jan. 16, 1998); (2) Australia-Measures
Affecting Importation of Salmon, WTO Doc. WT/SI 8/AB/R (Oct. 20, 1998); and (3) Japan-Measures
Affecting Agricultural Products, WTO Doc. WT/DS76/AB/R (Feb. 22, 1999).
31. See Commission Decision 97/878/EC, 1997 O.J. (L356) 64; Commission Decision 98/84/EC,
1998 O.J. (LI5) 43.
32. World Health Organization, Director-General Says Food Import Bans Are Inappropriate for
Fighting Cholera, Press Release, WHO24, Feb. 16, 1998 (visited Nov. 1I, 1999) <http://www.who.int/inf-
pr-I 998/en/pr98-24.html>; Food and Agriculture Organization, Import Ban on Fish Products from Africa
Not the Most Appropriate Answer, Press Release PR98-21 E, Mar. 25, 1998 (visited Nov. 1I, 1999)
<http://www.fao.org/waicent/ois/press-ne/presseng/1998/PREN982 I.HTM> [hereinafter FAO].
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industries in East African countries.3 Yet, to my knowledge, none of the
affected East African countries attempted to use the WTO's SPS regime to
bring the EU in line with international trade law. Many reasons potentially
explain this reticence to use the WTO on the part of African countries; for
example, any case brought would not have been resolved before the EU
import ban was scheduled to be lifted under its original terms (i.e., six
months). The usual remedy under WTO law is for the offending Member
State to bring its measures in line with international trade rules, but the
offending ban would have been lifted long before any WTO panel would have
addressed the issue. The EU in this case violated the SPS regime in
connection with developing countries with impunity.
More worrisome, because it directly affects health in developing
countries, has been the use of international trade law and international trade
institutions to open developing country markets to tobacco exports from
developed country companies. In the 1980s, the United States vigorously used
international trade law and GATT institutions to pry open developing
countries for the tobacco exports of U.S. tobacco enterprises. s4 In the Thai
Cigarette Case, the United States succeeded in convincing a GATT panel to
strike down a Thai ban on the importation of foreign tobacco products." The
United States claimed that the ban violated the national treatment principle in
GATT (Article III) and could not be justified under the GATT provision
allowing contracting parties to protect human health (Article XX(b)).36 The
GATT panel agreed with the United States that the ban violated the national
treatment principle because it allowed Thai, but not foreign, tobacco products
to be sold and because the ban was not the least restrictive trade measure
available to the Thai government to achieve its public health objective.37 The
United States' tobacco trade offensive inthe 1980s coincided with dramatic
increases in the consumption of tobacco products in developing countries.s
Underneath the international trade lawyering was the long-term strategy
of Western tobacco companies to find new markets because their existing,
lucrative markets in developed nations were stagnating and facing future
33. FAO, supra note 32 (stating that fish exports from "Kenya, Mozambique, Uganda and Tanzania
to the EU amounted to around 55,000 tonnes in 1996 worth $230 million. The EU is their most important
market for these products").
34. See Taylor, supra note 23, at 264.
35. See Thailand-Restrictions on Importation of and Internal Taxes on Cigarettes, Nov. 7, 1990,
GATT B.I.S.D., (37th Supp.) at 200 (1990).
36. Id. at 206-07.
37. Id. at 223, 225-26.
38. Taylor, supra note 23, at 264.
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decline. Developing countries made ideal emerging markets because they did
not have the sophisticated public health and regulatory systems that were
increasingly making tobacco companies' lives in developed countries difficult.
In addition, Western tobacco companies could effectively sell their tobacco
products by packaging them as Western cultural products; buying Marlboro
cigarettes was one way to sample Western lifestyle. The cultural linkage in
the tobacco conglomerates' strategy also received a boost from the end of the
Cold War and the collapse of communism because liberalism and the ways of
the West had triumphed and faced no universal challengers for the hearts,
minds, and pocket books of people living in developing countries. The
dramatic turn of developing countries toward free-market economics
paralleled that of civil societies as individuals increasingly desired what the
West offered for consumption, both philosophically and culturally. Western
tobacco companies succeeded in riding the waves of international trade law,
liberal triumphalism, and globalizing Western culture in penetrating the
markets and lungs of millions of people in the developing world.
Another feature of the increased globalization of markets through
international trade is the concern that processed food exports from developed
countries adversely affect the dietary habits of peoples in developing
countries. This concern links with the warnings from WHO about the global
obesity pandemic. 9 Public health experts have traditionally viewed obesity
as a health problem in affluent countries. While some traditional practices of
cultures in developing regions foster the development of obesity,4" this health
problem has affected mostly rich countries. Now WHO is worried that the
globalization of markets for processed food products may contribute to
negative changes in the dietary habits of peoples in developing countries."
As with tobacco consumption, these dietary transformations also represent
part of the globalization of Western culture as some people's lives in
developing countries begin to look more like the sedentary lifestyles
established in the West than the traditional habits and patterns of the native
culture.
39. World Health Organization, Obesity Epidemic Puts Millions at Riskfrom RelatedDiseases, supra
note 17.
40. World Health Organization. Obesity: Take It Seriously, Deal With It Now, supra note 17 ("In
some traditional societies, pressure is exerted on women to gain weight and remain overweight during their
reproductive lives.").
41. On the globalization of the markets for processed foods, see U.S. Department of Agriculture.
Globalization of the Processed Foods Market (visited Sept. 27, 1999)
<http://www.econ.ag.gov/epubs/pdf/aer742/index.html>.
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From the perspective of health in developing countries, the globalization
of markets has negative aspects, as it has made products available to people
that adversely affect health. In addition, the consumption of these products
also represents consumption of Western culture--"Taste Marlboro Country"
and "Drink the Real Thing." The globalization of markets plays a significant
role in the increasing threat of non-communicable diseases related to tobacco
consumption and poor dietary practices occurring in developing countries
today.
But the globalization of markets through international trade has not greatly
decreased the burden of infectious diseases in developing countries because
the transnational flow of goods has done little to ameliorate the underlying
problems of poverty that continue to stimulate pathogenic microbes.
Generally, the persistence of poverty suggests that many developing countries
have not had much success in fostering economic development through
participation in the international trading system. While some Asian countries,
once considered developing, have advanced to the ranks of industrial, affluent
countries through export-driven strategies, many developing countries,
particularly in Africa, have not achieved such trade-based economic
development. In fact, some evidence suggests that Africa has fallen behind
as the globalization of markets has accelerated world-wide economic growth.
In 1980, African exports represented 5.9 percent of world exports; but, in
1996, that share had fallen to 2.3 percent.4 2
These figures suggest that Africa has been marginalized in the world
trading system in the past twenty years. Such marginalization contributes to
the continued lack of economic development in African countries, and thus to
the kind of social conditions that provide opportunity for infectious diseases.
Why this marginalization of African countries has occurred is a complicated
matter that I do not have time to explore thoroughly here, but some factors
include African reliance on primary commodity exports, fluctuating world
commodity prices, protectionist import policies and regional trade agreements
in developed regions of the world, and the internal policies of African
governments (such as protectionism against imports). The Trade and
Development Centre, ajoint venture of the World Bank and WTO, has argued
that "the most critical factor responsible for Africa's poor trade performance,
is the protectionist policies adopted by most African governments
42. Trade and Development Centre, Country Studies: Africa (1997) (visited Sept. 10, 1999)
<http://www.itd.org/issues/africa0.htm>.
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themselves."'43 The policy implications of this view, of course, are that
African governments need to further liberalize their economies to international
trade in order to boost economic development. Increased economic
development would reduce poverty and improve the ability of African
governments to address public health problems. In this pattern of reasoning,
we can see neo-liberal economic assumptions embedded in the health
transition strategy.
I do not mean to imply that liberal or neo-liberal economic assumptions
were always embedded in thinking about the health transition strategy because
this strategy came of age during the Cold War when debates about the proper
path to economic development were rife in international relations. My point
is twofold: (1) that the health transition strategy assumes economic
development will occur in developing countries; and (2) that, in the era of the
globalization of markets, neo-liberal economic thinking dominates discourse
about how developing countries can achieve economic development. As the
position of the Trade and Development Centre makes clear, the neo-liberal
view of the continued lack of economic development in developing countries
faults the internal, protectionist policies of African governments, not the
structure and dynamics of international trade law and globalized markets. The
failure to experience the health transition is, in other words, largely self-
inflicted. In addition, the logic of this neo-liberal position suggests that
African countries' lack of preparedness for the emergence of non-
communicable diseases is also largely self-created.
My discussion of the impact of increases in international trade contains,
thus, two images: (1) the globalization of markets threatening health in the
developing world through the spread of products and cultural practices that
increase non-commun icable diseases; and (2)the failure ofdeveloping country
governments to adopt appropriate, neo-liberal domestic reforms to partake
fully in the globalization of markets, resulting in continued poverty and
inability to address existing infectious or emerging non-communicable disease
problems. One image shows health in the developing world as the victim of
the globalization of markets; the other image depicts health in the developing
world as victim to government policies that prevent people from enjoying the
full economic benefits of international trade and the globalization of markets.
Neither is a completely accurate view of the situation, but I am more
interested in what both images actually agree on-that the globalization of
43. Id.
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markets involves radical transformations of traditional cultures. I come back
to this point in Part IV, when I analyze globalization's impact on traditional
medicine.
B. Structural Adjustment Programs and Health in Developing Countries
Structural adjustment programs (SAPs), used by the World Bank and the
IMF in making loans available to developing countries, have become very
controversial in the 1990s. The World Bank and IMF use SAPs to restructure
the economies of developing countries that are suffering severe economic
problems. As a condition for receiving further loans, a developing country
often has to promise the World Bank or IMF that it will undertake
fundamental structural adjustments in its economy. These adjustments
involve removing barriers to exports and imports, deregulation of the
economy, reduction of budget expenditures, and increasing the attractiveness
of the economy to foreign investors. The World Bank and IMF believe that
SAPs promote the building of the appropriate economic conditions and
institutions that will generate and sustain economic development, and
integrate the developing State's economy with the global economy. SAPs are
based on the liberal or neo-liberal model of economic growth and
development.
Critics have attacked SAPs as being bad for people in developing
countries." While these criticisms often encompass many economic and
social sectors, the impact of SAPs on health in developing countries has been
a frequent target of SAP critics.45 In caricature, health-based critiques of
44. See, e.g., War on Structural Adjustment Programmes! (visited Sept. 3, 1999)
<http://parsons.iww.orgl-iw/novlstories/women-imf.html> (NGO participants at 1995 International
Women's Conference in Beijing stated that "we declare war against all IMF-dictated Structural Adjustment
Programmes (SAPs). These programmes have traumatised whole continents, tom apart the social fabric
of entire societies and are wreaking havoc on the lives of billions of people worldwide, especially women.");
J. Munoru, IMF and World Bank Policies, AFRICAN PERSPECTIVE, Nov. 14, 1998 (visited Mar. 26, 1999)
<http://www.africanperspective.com/htmll0/imf.html> (arguing that in Zimbabwe SAPs "have been a
disaster for the workers, peasants and young people"); Statement of the Local Civil-Society Steering
Committee of the Structural Adjustment Participatory Review Initiative, SAPRI, on the Serious Situation
in Ecuador, Mar. 11, 1999 (visited Mar. 26, 1999) <http://www.igc.apc.org/dgap/saprin/eccris.html>
(arguing that "[a]lfter 18 years of 'stabilization and adjustment' policies, the results continue to be
catastrophic for the poor, and the failure of structural adjustment couldn't be more evident").
45. See, e.g., Emma Curtis, Child Health and the International Monetary Fund: The Nicaraguan
Experience, 352 LANCET 1622 (1998) (analyzing negative impact of SAPs on health in Nicaragua); Carol
Riphenburg, Women's Status and Cultural Expression: Changing Gender Relations and Structural
Adjustment in Zimbabwe, 44 AFR. TODAY 33 (1997) (arguing that women's health in Zimbabwe is in
jeopardy because of SAPs); Imogen Evans & David Westaby, Structural Adjustment Too Painful? 344
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SAPs blame them for sacrificing public health and health care on the altar of
neo-liberal economic policy. The budgetary changes imposed through SAPs
force developing country governments to cut back expenditures ol public
health and health care systems. Often users' fees are imposed on patients in
an attempt to cover costs no longer borne by the government, but the poor
often cannot afford to pay such fees.46 The SAP-driven macroeconomic
changes, the general argument goes, reduce both the quality of and the access
to health services. While adverse health consequences of SAPs appear
throughout populations, particularly vulnerable groups-such as women,
children, and persons with HIV/AIDS-suffer the most. The adverse health
impact of SAPs in developing countries undermines fulfillment of the human
right to health proclaimed in the WHO Constitution47 and international human
rights documents.48
These worries about SAPs connect with more general concerns about the
globalization of markets, public health, and health care. At a general level, the
health-focused criticisms of the policies of the World Bank and IMF are
concerned about the power these international financial organizations wield
in developing countries. This power directly relates to the triumph of
liberalism over communism, as the World Bank and the IMF prescribe the
detailed, neo-liberal economic conditions for developing countries to receive
further international loans. Many people in developing countries also believe
that the general liberalization of (1) international trade encouraged by
GATT/WTO, NAFTA, and other neo-liberal international trade agreements;
and (2) the legal regime regulating foreign investment encouraged by bilateral
LANCET 1377 (1994) (arguing that SAPs wreaked havoc on the health and welfare of people in sub-Saharan
Africa); Angela M. Wakhweya, StructuralAdjustment and Health, 311 BRIT. MED. J. 71(1995) (criticizing
SAPs for making health worse for rural people in Africa); John W. Peabody, Economic Reform and Health
Sector Policy: Lessons from Structural Adjustment Programmes, 43 SOC. SCI. MED. 823 (1996); A. D.
Kiwara, Structural Adjustment Programmes and Health: Gender Implications 20, Paper Presented at
TGNP Seminar (Aug. 24, 1994) (arguing that SAPs "have real negative consequences on the health of
society, but more so on women because of their disadvantaged position in society").
46. See, e.g., JEAN LENNOCK, PAYING FOR HEALTH: POVERTY AND STRUCTURAL ADJUSTMENT IN
ZIMBABWE 20-22 (1994) (criticizing the increase in users' fees in Zimbabwe as a result of a SAP).
47. WORLD HEALTH ORGANIZATION CONST., supra note 5 ("The enjoyment of the highest attainable
standard of health is one of the fundamental rights of every human being without distinction of race,
religion, political belief, economic or social condition.").
48. See, e.g., European Social Charter, Oct. 18, 1961, art. II, 529 U.N.T.S. 89, 104; International
Covenant on Economic, Social, and Cultural Rights, Dec. 16, 1966, art. 12, 993 U.N.T.S. 3, 8; Banjul
Charter on Human and Peoples' Rights, June 27, 1981, art. 16, 21 i.L.M. 58, 61; United Nations
Convention on the Rights of the Child, Nov. 20, 1989, art. 24,28 i.L.M. 1456, 1465; Additional Protocol
to the American Convention on Human Rights in the Area of Economic, Social, and Cultural Rights,
Nov. 14, 1988, art. 10, 28 i.L.M. 156, 164.
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investment treaties, places extraordinary pressure on governments of
developing countries to reform fiscal and economic policy priorities. In order
to trade and to attract foreign investment in a world of intense global
competitive forces, developing country governments have to compete for
business and investment for their citizens and enterprises. The need to
compete forces these governments to transform, sometimes radically, social
and economic priorities in order to advance free market economics. One of
the priorities suffering under the disciplines imposed by globalized markets
is government-sponsored health programs. In addition, some people fear that
the radical economic changes, produced by a developing country joining the
globalization scramble, erode traditional economic structures closely linked
with indigenous societies and cultures. Even absent direct pressure from
international financial organizations through SAPs, developing countries face
economic development challenges that result in health, the right to health, and
traditional cultures being sacrificed on the altar of globalized neo-liberal
economics.
Combining these conclusions with the analysis on increases in
international trade in Part lI.A above, the neo-liberal economic structure and
the dynamics of the globalized world economy look very hostile toward health
in developing countries. Developed countries' use of international trade
regimes and the trade liberalization they encourage to export unhealthy
products to developing countries has led to increases in non-communicable
diseases, without significant positive impact on the burden of infectious
diseases. SAPs required by international financial organizations and general
competitive pressures from global markets for goods, services, and capital
force developing countries to reorganize their public health and health care
systems to accommodate the global market, which results in the undermining
of public health resources and the right to health.
C. International Trade in Services and Service Investments
Another aspect of the globalization of markets with the potential to affect
health in developing countries is the increase in international trade in services
and investments in the service sectors. These phenomena accentuate problems
already raised in this Article, but it is worthwhile to spell them out more
clearly. International investments in service industries include fast-food
restaurants, and U.S. fast-food companies have been rapidly expanding their
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global investments in the last decade.49 The first wave of fast-food investment
expansion went into developed countries in Europe and Asia; the second wave
into "transition economies" in Eastern and Central Europe; the third wave is
now breaking on the economies of developing countries." From a health
perspective, the penetration of U.S. fast-food into the diet and lifestyles of
developing country societies forms part of the concerns about the emerging
epidemic of obesity-related, non-communicable diseases. In addition, U.S.
fast-food restaurants market more than unhealthy food; they market this food
as part of the selling of U.S. culture. A trip to McDonald's in a developing
country is more than a quick meal; it is part of tasting a lifestyle and culture
vastly different from the ones surrounding the customers. During a trip to
South Africa, I was told that many poor people save money specifically to buy
a meal at a McDonald's restaurant. While perhaps this thrift is (mis)directed
at acquiring a tasty meal, more is involved with this phenomenon than the
consumption of food. The cultural features of this type of behavior factor into
the growing problem of obesity-related, non-communicable diseases.
Another important phenomenon to note is the increase in the international
trade in health services.5 More and more people are seeking health services
in other countries,5" and health service providers are increasingly marketing
their services to foreigners as well." Developed countries currently dominate
the provision of cross-border health services, 4 and developing countries are
49. For example, McDonald's now "operates more than 24,500 McDonald's restaurants in 116
countries on six continents." 25 Fascinating Facts About McDonalds's International (visited Sept. 27,
1999) <http://www.mcdonalds.com/surftheworld/facts/index.html>.
50. See. e.g., id. (noting McDonald's first investments in Europe, Japan, and Australia were in 1971,
while its first investment in Africa was in 1972).
5 I. Mario Marconini, Domestic Capacity and International Trade in Health Services: The Main
Issues, in INTERNATIONAL TRADE IN HEALTH SERVICES: A DEVELOPMENT PERSPECTIVE 55, 55 (Simonetta
Zarrilli & Colette Kinnon eds., 1998) [hereinafter INTERNATIONAL TRADE IN HEALTH SERVICES] (noting
"the expansion which has occurred in the last few decades in the [health services] sector's international
trade").
52. Id. (noting "a considerable increase in the global demand for health services").
53. David C. Warner, The Globalization of Medical Care, in INTERNATIONAL TRADE IN HEALTH
SERVICES, supra note 5 I, at 71, 75 ("There has been a rapid growth in international marketing by medical
facilities in Europe, the United States, and elsewhere.").
54. Orvill Adams & Colette Kinnon, A Public Health Perspective, in INTERNATIONAL TRADE IN
HEALTH SERVICES, supra note 5 I, at 35, 49 (noting that "cross-border trade in health services flows chiefly
from North to South"); GustaafWolvaardt, Opportunities and Challengesfor Developing Countries in the
Health Sector, in INTERNATIONAL TRADE IN HEALTH SERVICES, supra note 51, at 63, 63 (noting that "it
is predominantly developed countries that are taking advantage of the opportunity to provide health services
in a globalized market").
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emerging markets for high-tech medical services, such as telemedicine."
Some developing countries are, however, starting to market their health
services to potential consumers in both the North and the South.56 Within this
burgeoning activity in the globalization of health services, many issues arise
that concern those worried about health in developing countries. One concern
is that the globalization of health services may increase the flow of trained
medical personnel from the developing to the developed world." Another is
that governments will encourage "health care exports" at the expense of public
health and health care for the domestic society." Participating in the
international trade in health services could also accentuate the already heavily
criticized penchant of developing country governments to invest in modern,
high-tech hospitals and other health care resources that are not appropriate for
the health problems facing most of the society and that end up benefitting only
the elite and powerful.59 Even telemedicine, which many see as offering great
benefits for health in developing countries, has its long term downside in that
it could perpetuate developing countries' health dependence on the developed
world. In addition, telemedicine might be largely geared toward Western-style
health care services that do not address the most serious health threats facing
the majority of the populations in developing countries.60
More generally, the liberalization of international trade in services has
produced opportunities for insurance companies in deyeloped countries to
penetrate new markets.6 As insurance companies seek new customers in
developing countries, governments may find it easier to move away from
55. See generally Salah H. Mandil, Telehealth: What Is It? Will It Propel Cross-Border Trade in
Health Services?, in INTERNATIONAL TRADE IN HEALTH SERVICES, supra note 51, at 79.
56. Wolvaardt, supra note 54, at 63 (noting that "a limited number of developing countries such as
Cuba, India and Jordan are currently competing at a significant level").
57. Adams & Kinnon, supra note 54, at 36-39 (analyzing movement of persons supplying health
services).
58. Wolvaardt, supra note 54, at 68 (noting dangers of international trade in health services including
(I) a brain-drain of health care professionals; (2) an outflow of financial resources through cross-border
flow of patients; and (3) the creation of a two-tier health care system with foreign patients receiving higher
quality care).
59. Adams & Kinnon, supra note 54, at46 (expressing the concern that a foreign commercial presence
in the health sector through hospitals or health insurance programs would likely only produce gains for
affluent segments of populations in developing countries).
60. See Mandil, supra note 55, at 93 (cautioning that telemedicine is not "more important or more
effective than tackling the basic causes of poor health: poverty, lack of clean water, basic nutrition and
sanitation").
61. See generally J. Frangois Outreville, The Health Insurance Sector: Market Segmentation and
International Trade in Health Services, in INTERNATIONAL TRADE IN HEALTH SERVICES, supra note 5 1,
at II].
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universal systems of health care coverage to a privatized system in which
many people insure themselves for health care costs. Thus, liberalized
international trade in health services has synergy with the pressures many
developing country governments face in reducing public expenditures. The
fear is, of course, that the privatization of health care systems, made easier by
the availability of private health insurance, undermines the principle of
universal access to health care.
Increased international trade and investment in health and other services
plays an important role in how globalization affects health in the developing
world. Even more than trade, the international trade in services is dominated
by developed countries and the benefits for developing countries of this trade
are not always clear, as indicated above by the analysis of international trade
in health services. Cross-border investment in certain service sectors, such as
fast-food, may contribute to the growing problem of diet-related, non-
communicable diseases in developing countries. International trade in health
services may weaken national public health and health care systems in
developing countries by shifting resources and policy priorities away from the
real threats to health in the country. From the perspective of developing
countries, the growth in international trade in health services looks like a
"trickle down" health policy: the changes clearly benefit those with resources,
with the hope that the ripple effects of the benefits will eventually flow to the
poor. However, legitimate doubts may be raised about the propriety of such
an approach.
D. Intellectual Property and Health in Developing Countries
Another prominent feature of globalization that affects health in
developing countries is the emerging international legal regime protecting
intellectual property. Developed countries, led by the United States, have
pushed the protection of intellectual property rights near the top, if not to the
top, of the agenda of the global trading system. In the GATT/WTO system,
developed countries succeeded in conditioning WTO benefits for trade in
goods on Member States' accepting obligations to accord intellectual property
rights greater protection through the mandatory Agreement on Trade-Related
Aspects of Intellectual Property Rights (TRIPS).62 This linkage of trade
62. Agreement on Trade-Related Aspects of Intellectual Property Rights, Apr. 15, 1994, Marrakesh
Agreement Establishing the World Trade Organization, Annex IC, LEGAL INSTRUMENTS-RESULTS OF THE
URUGUAY ROUND vol. 31; 33 I.L.M. 81 (1994) [hereinafter TRIPS].
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benefits to intellectual property protection has forced many developing
countries to change their approaches to intellectual property rights; prior to
TRIPS, for example, many did not recognize patents on pharmaceutical
products.63 Some States "fear that TRIPS requirements for intellectual
property rights could lead to a higher cost burden for newer, patent-protected
essential drugs, further reducing access to health care."'t Given that "one-
third of the world's population has no guaranteed access to essential drugs,"65
further reduction of access because of TRIPS constitutes a public health
concern for developing countries.
Western pharmaceutical companies have, for example, been severely
criticized by many NGOs working on their pricing policies for HIV/AIDS
therapies that have proven successful in the United States and Europe. With
ninety-five percent of the world's HIV-infected people now living in the
developing world,' most of the people affected by this pandemic do not have
access to successful therapies because they are too expensive.67 Part of the
expense flows from the intellectual property rights that pharmaceutical
companies hold over the drugs in question. The same fears arise in connection
with any future development of an effective HIV vaccine. Pharmaceutical
companies (and their government backers) in the developed world defend the
rigorous protection of intellectual property rights because such rights make it
economically possible for new drugs to be developed in the first place.
Without the monopoly right accorded by a patent, a pharmaceutical company
would be much less likely to engage in innovative research and development.
The controversy about the need for access to HIV/AIDS therapies in the
developing world and the pharmaceutical industry's fierce protection of
intellectual property rights has come to a head on the issue of compulsory
licensing of patents by developing countries as they attempt to deal with their
HIV/AIDS epidemics. Compulsory licensing would involve the government
of a developing country issuing licenses to local firms to manufacture lower
63. Bernard Pdcoul et al., Access to Essential Drugs in Poor Countries: A Lost Battle?, 281 JAMA
361, 365 (1999) (noting the importance of TRIPS "because many developing countries do not fully
acknowledge patent protection rights for pharmaceuticals").
64. World Health Organization, WHO to Address Trade and Pharmaceuticals, May 22, 1.999 (visited
Sept. 10, 1999) <http://www.who.int/inf-pr-I999/en/pr99-whal 3.html>.
65. World Health Assembly, Revised Drug Strategy, WHA 52.19, May 24, 1999 (visited Sept. 16,
1999)<http://www.who.int/wha-1998/WHA99/PDF99/e-reso.pdf>. For a general analysis on the problems
in developing countries with access to essential drugs, see Pdcoul et al., supra note 63.
66. UNAIDS, supra note 13, at 2.
67. AIDS in the Third World: A Global Disaster, ECONOMIST, Jan. 2, 1999, at 42, 42 ("The poor
cannot afford to spend S10,000 a year on [HIV/AIDS] wonder-pills.").
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cost, generic versions of expensive, patented HIV/AIDS drugs. Many
HIV/AIDS activists have been calling for developing country governments to
use compulsory licensing as a way to help increase access to HIV/AIDS
therapies. TRIPS allows for compulsory licensing of patents in certain
situations,68 but Western pharmaceutical companies and important developed
countries, such as the United States, vigorously oppose compulsory licensing
of pharmaceutical patents.69 When South Africa and Thailand made legal
moves to allow compulsory licensing for patented HIV/AIDS drugs, the U.S.
government quickly put diplomatic and economic pressure on both
governments to turn them away from compulsory licensing.70 When South
Africa refused to change course, dozens of Western pharmaceutical companies
challenged the compulsory licensing law in South African courts."
The tension between the protection of patent rights and compulsory
licensing complicated WHO's adoption of a revised drug strategy. In January
1998, WHO's Executive Board recommended that the World Health
Assembly adopt a resolution that urged WHO Member States, inter alia, "to
ensure that public health rather than commercial interests have primacy in
pharmaceutical and health policies and to review their options under the
Agreement on Trade-Related Aspects of Intellectual Property Rights to
safeguard access to essential drugs."72 The World Health Assembly sent this
resolution back to the Executive Board in May 1998 because the controversy
it generated prevented its adoption. The Revised Drug Strategy resolution
adopted in May 1999 by the World Health Assembly urged WHO Member
States, inter alia, "to ensure that public health interests are paramount in
pharmaceutical and health policies; [and] to explore and review their options
68. TRIPS, supra note 62, art. 31.
69. See Merrill Goozner, Third World Battles for AIDS Drugs, CHI. TRiB., Apr. 28, 1999, § i, at I
(quoting a representative of the Pharmaceutical Research and Manufacturers Association as calling
compulsory licensing "a form of patent piracy" and "stealing;" and quoting Assistant U.S. Trade




72. World Health Organization Executive Board, Revised Drug Strategy, Jan. 27, 1998, § 1(2) (visited
Sept. 16, 1999) <http://www.who.int/gb/pdfangl/angr24.pdf>.
73. See World Health Assembly, Third Report of Committee A (Draft), May 15, 1998 (visited
Sept. 16, 1999) <http://www.who.int/wha-1998/pdf98/ea41.pdf> ("The Committee decided to refer
resolution EBIO1.R24 on 'Revised drug strategy' back to the Executive Board, to be further
considered... ,taking into consideration the discussions of this matter in the Committee and in a drafting
group.").
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under relevant international agreements, including trade agreements, to
safeguard access to essential drugs." '74
Opposition to compulsory licensing is also connected with concerns about
the potential misuse and abuse of antimicrobial drugs in developing countries.
Lack of control over the prescription and distribution of antimicrobial drugs
has contributed to the irrational use of such drugs and the resulting
development of antimicrobial resistance. In connection with the use of
antimicrobial drugs for both human and animal health purposes, many
developing countries have inadequate or non-existent regulatory controls over
antimicrobial use."' Antimicrobial resistance in such diseases as tuberculosis
and malaria has resulted from the undisciplined use and misuse of
pharmaceutical drugs in developing countries. With some strains of HIV
already developing resistance to HIV/AIDS therapies,76 concern exists that
widespread. compulsory licensing of HIV/AIDS therapies in developing
countries could increase the potential for the development of resistant strains
of HIV.77 While some developing countries may have the public health
infrastructure to administer HIV/AIDS drugs properly on a large scale, the
historical problems encountered in the developing world with the irrational
use of antimicrobials suggests that compulsory licensing of HIV/AIDS
therapies might have a significant long-term downside.78
Another controversial feature of intellectual property rights relates to the
historical practice of Western pharmaceutical companies exploiting for global
profit therapeutic remedies developed by traditional healers in developing
societies."9 Typically, a Western pharmaceutical company finds a compound
of therapeutic value in traditional medical practices, takes the compound back
to its headquarters, refines its chemistry, and patents the research and
74. World Health Assembly, supra note 65, § ](2)-(3).
75. David P. Fidler, Legal Issues Associated with Antimicrobial Drug Resistance, 4 EMERGING
INFECTIOUS DISEASES 169, 172 (1998); David P. Fidler, Legal Challenges Posed by the Use of
Antimicrobials in Food Animal Production, I MICROBES AND INFECTION 29,31 (1999).
76. See Luc Perrin & Amal io Telenti, HIV Treatment Failure: Testingfor HIV Resistance in Clinical
Practice, 280 SCIENCE 1871 (1998); Maureen Bezuhly et al., International Health Lv, 31 INT'L LAW. 645,
658 (1997).
77. Goozner, supra note 69 ("As part of its campaign to forestall widespread compulsory licensing,
the drug industry is raising concerns that poorly monitored use of the latest HIV inhibitors might create
resistant strains of the virus.").
78. For a detailed analysis of the factors producing drug resistance in developing countries, see Iruka
N. Okeke et al., Socioeconomic and Behavioral Factors Leading to Acquired Bacterial Resistance to
Antibiotics in Developing Countries, 5 EMERGING INFECTIOUS DISEASES 18 (1999).
79. See, e.g., Naomi Roht-Arriaza, Of Seeds and Shamans: The Appropriation of the Scientific and
Technical Knowledge of Indigenous and Local Communities, 17 MICH. J. INT'L L. 919 (1996).
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development, giving it the opportunity to reap monopoly profits without
returning anything to the society from which the knowledge originally came. 0
Critics of this behavior provocatively call it "biopiracy""' and
"biocolonialism; ''1 2 many developing countries have taken actions to prevent
Western pharmaceutical companies from "stealing" indigenous knowledge
without fair return for the investment of the indigenous society.83
The biopiracy controversy is important in terms of the impact of
intellectual property rights on developing countries, but it is also important in
what it tells us about Western attitudes toward traditional medicine. Western
pharmaceutical companies have viewed traditional medicine through
utilitarian lenses: what can we learn from traditional medicine that can be
transformed into modern, scientific therapies that make profits from patients
in the developed world? Traditional medicine has, thus, historically been
treated by Western pharmaceutical companies as a commodity, or a natural
resource of the periphery, to be exploited for the benefit of health in the core.
The resulting pharmaceutical products, protected by the international law on
intellectual property, are then exported back to developing countries, where
they largely benefit the rich and powerful because of their intended medical
purpose or cost. The cultural significance and health importance of traditional
medicine in many developing countries does not factor into this utilitarian
perspective or the international law on intellectual property,"4 and the
commodification of traditional medicinal knowledge tends to produce
pharmaceutical products that are too expensive to benefit health in developing
societies significantly or are irrelevant to the major health threats facing these
societies.
80. Keith Aoki, Neocolonialism, Anticommons Property, and Biopiracy in the (Not-So-Brave) New
World Order of International Intellectual Property Protection, 6 IND. J. GLOBAL LEGAL STUD. II, 49
(1998) (noting that "invaluable biological and cultural resources flowing out of the countries of the South
as 'raw materials' into the developed nations of the North where they are magically transformed in the
laboratories of pharmaceutical and agricultural corporations into protected intellectual properties whose
value is underwritten by provisions of multilateral agreements such as TRIPS").
8 1. See, e.g., VANDANA SHivA, BIOPIRACY: THE PLUNDER OF NATURE AND KNOWLEDGE (1996).
82. Aoki, supra note 80, at 52.
83. See K. S. Jayaraman, India Seeks Tighter Controls on Germplasm, 392 NATURE 536 (1998);
Ehsan Masood, Old Scores Surface as African States Face New Opportunities, 392 NATURE 540 (1998);
Ricardo Bonalume Neto, Brazil's Scientists Warn Against 'Nationalistic'Restrictions, 392 NATURE 538
(1998).
84. But see the ongoing debate about expanding intellectual property rights to cover indigenous
knowledge and its products analyzed in Roht-Arriaza, supra note 79, at 953-58; Rosemary J. Coombe,
Intellectual Property, Human Rights & Sovereignty: New Dilemmas in International L,v Posed by the
Recognition of Indigenous Knowledge and the Conservation of Biodiversity, 6 IND. J. GLOBAL LEGAL
STUD. 59, 77-82 (1998).
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III. GLOBALIZATION OF MARKETS AND THE HUMAN RIGHT TO HEALTH
As mentioned in Part II, one strategy frequently used to counter the
perceived adverse health consequences of the globalization of markets is an
appeal to the human right to health. Some believe that the imposition of neo-
liberal economic policies on developing country governments through SAPs
forces them to violate the right to health by cutting back spending on public
health and health care. 5 Some argue that the international intellectual
property regime's restriction of access to essential drugs violates "a basic
human right." 6 The "right to health" argument is powerful rhetorically, and
many people working in health sectors in developing countries passionately
believe that every individual has a fundamental right to health. Thus, the
globalization of markets becomes an enemy of the basic human right to health,
particularly in connection with developing countries.
Unfortunately for these arguments and passions, the human right to health
remains an amorphous concept. No one is really sure what it means.8 7 In
December 1998, WHO's Director-General defined "health security" as
encompassing a right to health care, food, water, shelter, education, and a safe
environment.88 The problem with this kind of definition is that it suggests that
the right to health means a right to almost everything. As one commentator
argued, "if the right to health covers everything, then it means nothing."8 9
Even more problematic is the manner in which the concept of the right to
health is actually enshrined in international law. The right to health is an
economic, social, and cultural right-one of the "second generation" of human
rights." As contained in international human rights agreements, State parties
accept the obligation to realize progressively the right to health while taking
into account their economic circumstances.9' An individual's enjoyment of
the right is dependent on, or relative to, the State's economic resources. This
85. See arguments about adverse health impacts of SAPs cited supra note 45.
86. See Statement of Consumers International delivered by Ellen cet Hoen on Agenda item 13 of the
52nd World Health Assembly: Revised Drug Strategy, May 22, 1999 (arguing that "[aiccess to essential
drugs is a basic human right").
87. FIDLER, supra note 26, at 181 ("Lamentations about the difficulty of determining the content of
the right to health populate the literature on the right to health.").
88. World Health Organization, Director-General Sets Out WHO Stance on Health and Human
Rights, Dec. 8, 1998 (visited Sept. 12, 1999) <http://www.who.int/inf-pr-1998/en/pr98-93.html>.
89. Steven D. Jamar, The International Human Right to Health, 22 S.U. L. REV. I, 53 (1994).
90. FIDLER, supra note 26, at 179-80.
91. For an analysis on the principle of progressive realization and the right to health, see id. at 183-85.
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principle of progressive realization connects the right to health to economic
development. Thus, like the health transition strategy, the right to health
carries within it the requirement for sufficient economic development to
support well-funded public health and health care systems. Through the
primary health care (PHC) strategy, launched with the Health for All by the
Year 2000 policy in 1978,92 WHO attempted to create public health strategies
geared toward the socioeconomic conditions in developing countries. Despite
some progress, the PHC strategy has not had the impact on health in
developing countries originally hoped.93 The lack of widespread economic
development in the developing world, combined with the failure of public
health strategies designed to improve public health in developing countries,
has leftthe rightto health empty in the lives of people in developing countries.
A serious problem with using the right to health to criticize neo-liberal
economic policies and the globalization of markets is the conspicuous failure
to provide an alternative model of economic development. Fulfillment of the
right to health depends on the presence and effective use of economic
resources; thus, support for the right should be accompanied by ideas related
to how the country creates and utilizes economic development. I do not mean
to imply here that neo-liberalism and economic globalization are the only
possible policy avenues available to States and international organizations.
But it is frustrating to hear wonderful rhetoric about the right to health being
violated when the rhetoricians often have not thought it necessary to address
how a government in a developing country should go about creating economic
development. As noted earlier, supporters of neo-liberal models of economic
development fault governments, rather than globalization, for the lack of
economic development in developing countries. From this perspective, the
failure to realize progressively the right to health is, like the failure to
experience the health transition, largely self-inflicted. Again, we reach a stage
of finger pointing about the underlying problems burdening the health of
peoples in the developing world.
In the 1999 World Health Report, the WHO Director-General advocated
supporting health sector development through what she called a "new
universalism."' The essence of new universalism appears to be reliance on
92. See Declaration of Alma-Ata, supra note 6.
93. See Allyn L. Taylor, Making the World Health Organization Work: A Legal Framework for
UniversalAccess to the Conditionsfor Health, 18 AM. J.L. & MED. 301,302 (1992) (arguing that "[slince
WHO initiated the Health for All strategy [in 1978], disparities in health standards between rich and poor
nations have increased and health spending in most developing nations has declined").
94. Message from the Director-General, in WORLD HEALTH REPORT 1999, supra note I, at xv.
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market forces to produce the economic resources needed for the government
to provide universal access to health care. The Director-General seemed to
recognize the dominance of liberal and neo-liberal economic thinking by
acknowledging that health sector reform "will take place in a context of
increased reliance on the market forces which have increased productivity in
many sectors of the world economy."95 She also noted that "[m]arket
mechanisms have enormous utility in many sectors and have underpinned
rapid economic growth for over a century in Europe and elsewhere."96 The
new universalism rejects, however, using market forces to provide health
services because "[n]ot only do market-oriented approaches lead to intolerable
inequity with respect to a fundamental human right, but growing bodies of
theory and evidence indicate markets in health to be inefficient as well."97 She
noted that "the very countries that have relied heavily on market mechanisms
to achieve the high incomes they enjoy today are the same countries that rely
most heavily on governments to finance health services."9 8 The primary role
of the private sector in the new universalism is to supply drugs and equipment
to health service providers and to invest in new drugs and technology to
improve health." But it is the public sector that has "the fundamental
responsibility of ensuring solidarity in financing health care for all."'"
The extent of this fundamental responsibility is not clear, however, as the
Director-General warned governments cannot attempt "to provide and finance
everything for everybody."' 0 ' The new universalism "recognizes that if
services are to be provided for all then not all services can be provided."'' 2
New universalism maintains that "[t]he most cost-effective services should be
provided first."'0 3 The breadth and depth of the fundamental responsibility to
finance health care for all would seem to depend on the level of economic
development of the country in question, which itself depends on the breadth
and depth of the country's reliance on market forces and integration with the
global economy.
Whether the path to the progressive realization of the right to health
involves neo-liberalism, socialism, or WHO's new universalism, it will be a
95. Id. at xiv.
96. Id. at xiv-xv.
97. Id. at xiv.
98. Id. at xv.
99. id.
100. Id.
101. Id. at xiv.
102. Id. atxv.
103. Id.
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globalized path. The use of the right to health, and agitation by members of
transnational civil society for its realization, represents the globalization
phenomena itself. Global networks of NGOs, linked in the common cause of
the right to health and utilizing new information technologies to build
solidarity and exert influence, constitute creatures of globalization. The
enterprise is very distant from concepts of health in traditional cultures in
developing countries and constitutes a threat to traditional medicine. Further,
the scale of economic development needed to support the WHO Director-
General's definition of "health security" and her concept of "new
universalism" cannot be achieved except through connecting a national
economy to global markets for goods, technology, services, and capital. In
short, new universalism seems to admit that realistic and progressive
fulfillment of the right to health in developed, and especially developing
countries, requires the globalization of markets.
Do supporters of the right to health and new universalism have to cut a
Faustian bargain with the neo-liberal globalization of markets? New
universalists and right-to-health critics of neo-liberalism's version of the
globalization of markets may believe in the possibility of a kinder, gentler
globalization. New universalism seeks not only to harness the wealth-
producing forces of free markets, but also to protect public health and health
care systems from adverse consequences of free market activities. Even new
universalism's version of globalization will not, however, be kinder and
gentler for traditional cultures in developing countries. New universalism
would involve significant transformations of traditional practices, customs,
and mores because it would require radical action internationally, nationally,
and locally to stimulate market-inspired economic reforms and to address
systematically the burdens of infectious and non-communicable diseases.
IV. GLOBALIZATION AND TRADITIONAL MEDICINE
The assertion that the serious pursuit of the right to health would
undermine traditional cultures in developing countries may not trouble some
people committed to improving health in developing countries. In the global
era, the concepts of "health" and the "right to health" are intertwined with
Western scientific and technological approaches to human illness. This
particular outlook may be defensible in terms of what Western science and
medical technology have offered and potentially promise to offer
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humankind,"° but it does not deal with a very practical problem at the heart
of health problems in many developing States, particularly in Africa.
According to WHO, "[m]ost population[s] in the developing countries still
[rely] mainly on indigenous traditional medicine for satisfying their primary
health care needs."'0 5 In these societies, traditional medicine often has no
connection at all with Western conceptions of illness and health because it is
encapsulated in belief systems alien or antithetical to modern, Western
thought. From one perspective, the large-scale use of traditional medicine in
developing countries only serves to emphasize the extent of the failure of
national and international health policy to improve health conditions along
Western models."° It further serves as an illustration of the relative isolation
of these societies from the processes of globalization and their benefits.
This rather skeptical view of traditional medicine is currently not in
vogue. In fact, international and national public health experts are attempting
to formulate ways to meld traditional and Western forms of medicine to
improve health in developing countries. The reality that most people in
developing countries only have access to traditional medicine is not seen so
much as a failure, but as an opportunity to build a more effective and
culturally sensitive approach to public health and health care. Experts believe
that a melding strategy offers promise in developing countries for public
health and health care generally" 7 and in connection with specific disease
104. See Message from the Director-General, supra note 94, at vii (stating that "[r]emarkable gains
in health, rapid economic growth and unprecedented scientific advance-all legacies of the 20th century-
could lead us to a new era of human progress").
105. World Health Organization, WHO's Policy and Activities on the Traditional Medicine (visited
Sept. 13, 1999) <http://www.who.int/dap/trmO.html>.
106. See, e.g, Bernard Hours, African Medicine as an Alibi and as a Reality, in AFRICAN MEDICINE
IN THE MODERN WORLD 41,46 (Centre of African Studies ed. & Christopher Fyfe trans., 1986) (arguing
that "the rediscovery of African medicine ... works chiefly as an institutional alibi, designed to mask the
inadequacies of existing policies, in the hope that health problems will be solved by introducing some more
or less imaginary dimension"); Komla Tsey, Traditional Medicine in Contemporary Ghana: A Public
Policy Analysis, 45 SOC. SCI. MED. 1065, 1065 (1997) (arguing that "i]n Ghana, as in most African
countries, the rising cost of Westem medicine means that individuals and... governments are increasingly
turning to traditional medicine as an affordable alternative").
107. See, e.g., World Health Organization, supra note 105 (stressing "the need for the governments of
the countries interested in the use of traditional medical practice to give adequate support to engaging
traditional medical practitioners in primary health care teams"); L. Thikhoi Jonathan, Traditional Versus
Modern Medicine: The Case for a Collaborative Approach to Primary Health Care, in ETHNOMEDICINE
IN SOUTHERN AFRICA 9, 16 (National University of Lesotho Journal of Research ed., 1993) ("It is...
imperative that the two systems of medicine [modern and traditional] are brought together tnder one
umbrella for the benefit of the people they are intended to serve."). For an analysis on the policy debate
about integrating traditional and modern medicine in health policies of developing countries, see MELVYN
FREEMAN & MMATSHILO MOTSEI, Is THERE A ROLE FORTRADITIONAL HEALERS IN HEALTH CARE IN SOUTH
AFRICA? (1990). EDWARD C. GREEN, INDIGENOUS HEALERS AND THE AFRICAN STATE: POLICY ISSUES
NEITHER SCIENCE NOR SHAMANS
problems."" This melding strategy raises many interesting questions, many
of which draw attention to the relationship between globalization and culture.
Earlier, this Article pointed out globalization's potential to erode cultures in
developing countries. The intimate connection between traditional medicine
and its nurturing culture might, thus, find itself in the eye of globalization's
cultural hurricane. Whether traditional medicine can survive globalization to
contribute to improved health in developing countries remains to be seen, but
the future for traditional medicine may not be bright, despite the resurgence
of interest in traditional medicine.
Underneath the growing attention to traditional medicine as a feature of
global health policy are some worrisome issues. The globalization of markets
has not greatly accelerated the advance of Western-style public health and
health care in much of the developing world. In fact, as analyzed earlier in
this Article, many people think the globalization of markets is harmful to
health in developing countries. In addition, the globalization of markets has
had, and promises to have, an even greater impact on traditional cultures in
developing countries as economic policies and individual lifestyles
increasingly follow patterns already established in the West. Traditional
cultures are mutating or dying without access to the full political, economic,
and scientific benefits of the adopted Western culture. The health context
provides an interesting lens through which to look at this phenomenon,
particularly in connection with the future of traditional medicine.
Despite its importance in many developing countries, traditional medicine
is under stress from three major sources. The first source of stress is the long-
standing realization that governments in developing countries have to regulate
traditional medicine to prevent traditional healers from committing fraud,
inflicting injury, spreading disease, and causing unnecessary deaths."°
CONCERNING AFRICAN INDIGENOUS HEALERS IN MOZAMBIQUE AND SOUTHERN AFRICA (1996).
108. See, e.g., World Health Organization, Report of the Consultation on AIDS and Traditional
Medicine: Prospectsfor Involving Traditional Health Practitioners, WHO/TRM/GPA/90.1 (July 23-27,
1990); EDWARD C. GREEN, AIDS AND STDs IN AFRICA: BRIDGING THE GAP BETWEEN TRADITIONAL
HEALING AND MODERN MEDICINE (1994); Edward C. Green, The Participation of African Traditional
Healers in AIDS/STD Prevention Programs (visited Sept. 9, 1999)
<http://www.yg.cchs.usyd.edu.au/IHN/green i .him>.
109. See, e.g., Isaac Sindiga et al., The Future of Traditional Medicine in Africa, in TRADITIONAL
MEDICINE IN AFRICA 175, 176-78 (Isaac Sindiga et al. eds., 1995) (analyzing need for legislation,
registration, and licensing of traditional healers); GREEN, supra note 107, at 48-52 (analyzing the issue of
legislation and traditional healers); World Health Organization, supra note 108, at 13 (arguing for
legislation to regulate traditional medical practices); Salifou Dembdl6, Should Traditional African Medicine
Be Regulated?, 49 INT'L DIG. HEALTH LEGIS. 566, 566 (1998) (arguing that "co-existence between the rule
of law and traditional systems of African medicine is ... necessary").
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Despite comforting rhetoric about the importance of traditional medicine and
its importance in the daily lives of people in developing countries, the move
to regulate it is a move to Westernize traditional medical practices by moving
them onto a firmer scientific and legal basis. The move to regulate is also
influenced by human rights concepts, again largely derived from the West,
that frown upon certain traditional medical practices that are harmful to the
body, such as female circumcision. Shorn of politically correct sentiments,
the regulatory idea seeks to reform traditional medicine on scientific, public
health, and human rights grounds prevalent in the West."'
The second source of stress for traditional medicine comes from attempts
to link traditional and Western medicine together in improving public health
and health care in the developing world. Much of the talk of melding
traditional medicine and Western medicine is, at the end of the day, a
utilitarian project to improve the penetration of Western health practices and
technologies deeper into developing societies. The primary appeal of
traditional medicine is practical, not cultural. As Green argued:
Perhaps the most powerful argument is that public health
goals probably cannot be realized in Africa without some
type of collaboration involving indigenous healers. The
numbers simply are not there: the number and geographic
distribution of Western-trained medical personnel, the
number of clinics and hospitals in rural areas, and the amount
of money available to ministries of health are all inadequate
to meet existing needs. . . . Economic and manpower
arguments in favor of collaboration can only become stronger
in the foreseeable future."'
Traditional healers are, thus, viewed as unavoidable conduits for the
application of Western public health strategies and medical approaches in
developing countries. Western-trained public health experts and physicians
attempt to translate Western biomedical concepts into terms, symbols, and
beliefs already prevalent in traditional medicine."' However, those in favor
110. An interesting development to watch in this regard is the attempt by South Africa to set up a
statutory council to regulate traditional healers in South Africa. See Adele Baleta, South Africa to Bring
Traditional Healers into Mainstream Medicine, 352 LANCET 554 (1998).
II1. GREEN, supra note 108, at 38-39.
112. Green, supra note 108 (noting the need for "more effort to 'translate' biomedical concepts into
locally familiar terms (language, symbols, metaphors)" and the attempt through AIDS/STD prevention
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of collaboration between Western and traditional medicine do not usually
hesitate to condemn traditional medical practices that cannot be co-opted as
vessels for Western biomedical and public health knowledge." 3
"Learning" from traditional healers also seems to include finding ways to
improve Western health practices, primarily through new therapeutic
compounds refined over the ages in traditional medical environments. As
traditional medicine has come into vogue, sales and consumption oftraditional
remedies and resort to "alternative medicine" in developed and developing
countries has increased." 4 The Western interest in effective, traditional plant
and herbal remedies, is a component of the allegations of "biopiracy" against
Western pharmaceutical companies analyzed earlier in this Article. In
addition, some experts have noted that Western efforts to modernize
traditional plant and herbal remedies, through scientific research and
development, tend to make such remedies "more expensive and thereby
undermining ease of access often associated with traditional medicine.""' 5
While there is no hesitation on the part of Westerners to study and benefit
from traditional remedies, concerns exist about sharing Western
pharmaceutical products with traditional healers. One factor in the
development of antibiotic resistance in developing countries is the misuse of
antibiotics by unskilled practitioners, including traditional healers." 6
The third source of stress is general cultural erosion. Traditional medicine
belongs to ancient belief systems deeply embedded in many societies. The
"world views" of these belief systems are not compatible with the world view
that comes with Western science and medicine. Harnessing traditional
medicine to promote Western public health and health care approaches is
arguably a corrosive process because it undermines the foundations of
traditional belief systems." 7 While the traditional medical systems remain
programs "to teach biomedical concepts to traditional healers by using symbols, metaphors and etiological
concepts already in use").
113. See, e.g., Dembdle, supra note 109, at 567 (arguing that "the regulation of the practice of
traditional systems of medicine could not promote ... [dangerous] practices, despite the fact that they form
part of the sociocultural background .... Certain procedures carried out by traditional practitioners deserve
to be condemned in no uncertain terms and their 'art' expressly prohibited").
114. See World Health Organization, supra note 105 (discussing rise in international use of herbal
medicines and natural products).
115. Tsey, supra note 106, at 1073.
116. Okeke et al., supra note 78, at 19; GREEN, supra note 107, at 61 (noting "that there is great
potential for misuse of medicines and related technology of biomedicine, in the hands of 'untrained'
healers").
117. See, e.g., GREEN, supra note 108, at 42-43 (arguing that "meddling with traditional medicine is
fraught with unforseen [sic] and possible negative outcomes. One does not have to be an anthropologist
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part of daily life, the life force or energy behind them may drain away as
collaboration with Western science and medicine deepens."' More generally,
the globalization of markets creates stress for traditional cultures as global ized
trade, investments, urbanization, communications, and media encroach ever
more into societies previously unconnected (and perhaps unconcerned) with
the rest of the world. Once tempted by the allure of the global village, the
ways of the local village never seem quite the same." 9
One might challenge my sweeping assertions by pointing out the growing
popularity of traditional medicine in African countries. Even more broadly,
phenomena such as the "African renaissance"-a reawakening of traditional
African culture-suggest that traditional cultures are not on the verge of
extinction. However, the increase in popularity of traditional medicine and
the resurgence of interest in traditional culture do not undermine the thrust of
my arguments in the health context. Many commentators have pointed out the
simultaneous unification and fragmentation of the world in the era of
globalization. 2 Ethno-revivalism is, in many respects, a reaction to (or
against) the cultural ramifications of globalization, and is thus linked to
globalization as a phenomenon. In the health context, ethno-revivalism may
be seen in the increasing popularity of traditional medicine; it is, however,
open to question whether this popularity has or will have beneficial impact on
health in developing countries. Perhaps the increasing use of traditional
to recognize that healers play a complex role and carry out complex, interrelated functions in their
communities").
118. Hours argued that collaboration between modem and traditional medicine:
cannot conceal the different types of logic that underlie modern and African
medicine. The first has a chemical or technical approach. But African medicine is
concerned with power, with a struggle against the social disorders known as
witchcraft. Thus, we cannot hope to achieve a synthesis, some simple, radical
therapeutic syncretism.... Thrust into a system ruled by another logic, away from
their own village and society, traditional practitioners are ineffective and powerless.
Hours, supra note 106, at 56-57.
119. The tension between the traditional and the modern was captured in the following excerpt from
The Irish Times:
Although the roots of muti [a form of traditional medicine] lie deep in African
traditional religion, it has learned to move with the times. South African blacks now
live in an increasingly urbanised context, and the new wave of sangomas [a
traditional healer] has swapped smoky huts and animal skins for high rise offices,
sharp suits and framed certificates. But despite this new look image, the modern
sangoma still makes his or her diagnosis by throwing animal bones on to the floor
Edward O'Loughlin, It May Not Heal, But It Does Deter Burglars, IRISH TIMES, Nov. 28, 1995, available
in 1995 WL 12717654.
120. See, e.g., BENJAMIN R. BARBER, JIHAD VS. MCWORLD: HOW THE PLANET IS BOTH FALLING
APART AND COMING TOGETHER AND WHAT IT MEANS FOR DEMOCRACY (1995).
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healers reflects not pride in traditional culture, but desperation of people
increasingly under threat from old and new diseases.
The stress placed on traditional medicine from the movement to regulate
it, the plans to utilize it for better delivery of Western public health and health
care, and general cultural erosion will eventually render the concept of
"traditional medicine" less and less useful in the context of health in
developing countries.' In health and other contexts, worlds are literally
colliding; it is also apparent which world has the greater mass and momentum
to effectuate a change in the path it is following. The peoples of developing
countries will not, however, be swept entirely up in the wake of
globalization's impact as levels of economic development do not yet exist to
support Western-style public health and health care.
CONCLUSION
Globalization in economic and other areas of human interaction has
important consequences for the peoples of the developing world. Developing
country societies entered the era of globalization burdened with health
conditions far worse than in developed countries. The hoped-for health
transition from infectious to non-communicable diseases did not take place.
Instead, the health gap between developing and developed countries now
involves developing countries facing enormous health problems with both
infectious and non-communicable diseases, without levels of economic
development needed to deal with either. The processes of globalization and
their dynamics also contain aspects that appear to accentuate the health
problems of developing countries, whether through increases in international
trade, structural adjustment programs required by international financial
organizations, changes in the nature and extent of international trade and
investments in services, or the operation of the international intellectual
property regime. While the human right to health is often used to argue
against globalization and its health consequences, the underlying questions
about how to develop a country economically to improve public health and
health care are not usually addressed, let alone answered, in discourse on the
human right to health. Finally, the interaction between the forces of
globalization and traditional medical practices adds another worrisome
121. Some may assert, with some legitimacy, that colonialism and neo-imperialism destroyed what
traditional medicine was really about long before globalization came into fashion.
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wrinkle to the perspective of developing countries concerning globalization's
impact on health in the developing world.
On the horizon for health in the developing countries may be the worst of
all possible worlds: increasing disease burdens, continued lack of economic
development, continued lack of access to Western public health and health
care, and the erosion of the practices and the beliefs behind traditional
medicine. Peoples in developing countries may, thus, suffer a double cultural
alienation: falling short of the promises offered by Western science and
falling away from the cultural identity represented by shamans. This situation
portends great individual and societal discontent as globalization progresses.
